ah.novartis.comTiamutin home page

Commercial layer RPs

Replacement pullet programmes – commercial layers

Commercial layer RPs are frequently reared on Tiamutin-compatible anticoccidials or more recently coccidiosis vaccines, as producers want the birds to be immune by the time they reach the laying period. In this case the birds may be given the complete programme especially if they are coming from infected stock or are at high risk from contacting the infection during the rearing period.
 

Programme A – birds on Tiamutin-compatible ionophores or coccidiosis vaccines
 

Birds on Tiamutin-compatible ionophores or coccidiosis vaccines

 
 

In a French study, birds from a M. gallisepticum infected source were treated as above and compared with a similar flock treated with tylosin at 0.05%. In the first 12 weeks of laying the Tiamutin-treated birds produced 4.9% more eggs than the tylosin-treated group (80.67 eggs/HH Tiamutin; 76.89 eggs/HH tylosin) and the peak laying percentage was 8.84% higher (97.83% Tiamutin: 88.79% tylosin).
 


 

Tiamutin® (tiamulin), tylosin productivity comparison
No. of eggs in first 12 weeks/HH
Tiamutin® (tiamulin), tylosin productivity comparison
Peak laying percentage

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Programme B – birds on monensin during the rearing period
 

Pullets may be given the anticoccidial monensin, which is incompatible with Tiamutin, upto 16 weeks of age. In this case Tiamutin cannot be used until at least 7 days after monensin has been withdrawn from the feed. In this case Tiamutin administered at point of lay (20 weeks of age) to infected birds has been shown to be very effective in reducing egg production losses and improving peak laying percentage.
 

 
 

Birds on monensin during the rearing period

 
 

In a Polish study, birds infected with M. gallisepticum were treated with Tiamutin at 0.025% in the drinking water for 3 days at point of lay and compared with an untreated control. In the three month observation period the Tiamutin treated birds produced 17.2% additional eggs in comparison with the untreated controls (119.9 eggs/HH Tiamutin; 102.3 eggs/HH controls). Although egg weights were essentially the same the mortality rate of the hens during the observation period was reduced by 23.5%, primarily due to a marked reduction in the incidence of E. coli infections.
 


 

Comparison of productivity over 3 months
No. of eggs/HH

   Tiamutin is highly effective in controlling
   mycoplasma infections in replacement pullets
   and programmes for control can be varied to
   suit the individual farm and its management
   system.
 

 
 

   Tiamutin for flexible and effective
   control of mycoplasma infections

 


 

Back to the top

Novartis.com home | Contact | Help | Legal Disclaimer | Privacy Policy
© 2007 Novartis Animal Health Inc.
Please note that not all products listed within this site may be available in all countries.
Also, prescribing information and indications for products may differ from country to country, so please
consult your local veterinarian for local prescribing and any other information you may be interested in.